Log in
Enquire now
‌

US Patent 9388144 Radiolabeled prostate specific membrane antigen inhibitors

Patent 9388144 was granted and assigned to Molecular Insight Pharmaceuticals, Inc. on July, 2016 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
‌
Molecular Insight Pharmaceuticals, Inc.
Current Assignee
‌
Molecular Insight Pharmaceuticals, Inc.
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9388144
Date of Patent
July 12, 2016
Patent Application Number
14553157
Date Filed
November 25, 2014
Patent Citations Received
0
Patent Primary Examiner
‌
Michael G. Hartley
Patent abstract

Compounds according to Formula I and Formula II are potent inhibitors of PSMA activity:

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9388144 Radiolabeled prostate specific membrane antigen inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.